Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P86
Within normal range
vs 2Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 22.10% |
| Q2 2025 | 34.91% |
| Q1 2025 | -159.60% |
| Q4 2024 | 18.65% |
| Q3 2024 | -43.94% |
| Q2 2024 | 16.73% |
| Q1 2024 | -164.44% |
| Q4 2023 | -10.62% |
| Q3 2023 | 21.07% |
| Q2 2023 | 43.71% |
| Q1 2023 | -386.81% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |